[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Arcturus Therapeutics Ltd (ARCT)

Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 382,289
  • Shares Outstanding, K 28,423
  • Annual Sales, $ 82,030 K
  • Annual Income, $ -65,780 K
  • EBIT $ -102 M
  • EBITDA $ -99 M
  • 60-Month Beta 2.39
  • Price/Sales 3.81
  • Price/Cash Flow N/A
  • Price/Book 1.82

Options Overview Details

View History
  • Implied Volatility 111.89% (+11.77%)
  • Historical Volatility 109.59%
  • IV Percentile 58%
  • IV Rank 16.34%
  • IV High 339.05% on 01/02/26
  • IV Low 67.51% on 05/22/26
  • Expected Move (DTE 25) 2.39 (17.93%)
  • Put/Call Vol Ratio 0.47
  • Today's Volume 254
  • Volume Avg (30-Day) 634
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 5,589
  • Open Int (30-Day) 4,350
  • Expected Range 10.93 to 15.71

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.60
  • Number of Estimates 4
  • High Estimate $-0.29
  • Low Estimate $-0.87
  • Prior Year $-0.49
  • Growth Rate Est. (year over year) -22.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.57 +137.70%
on 07/28/26
13.50 -1.93%
on 08/21/26
+7.71 (+139.42%)
since 07/24/26
3-Month
5.50 +140.73%
on 07/24/26
13.50 -1.93%
on 08/21/26
+6.21 (+88.34%)
since 05/22/26
52-Week
5.50 +140.73%
on 07/24/26
24.17 -45.22%
on 10/21/25
-5.27 (-28.47%)
since 08/22/25

Most Recent Stories

More News
Arcturus Therapeutics: Q2 Earnings Snapshot

Arcturus Therapeutics: Q2 Earnings Snapshot

ARCT : 13.69 (+1.78%)
Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress

ARCT-032 (CF) Phase 2 study enrollment remains on schedule; the decision to proceed into Phase 3 expected Q4 2026 ARCT-810 (OTC Deficiency) Phase 2 study enrollment and...

ARCT : 13.69 (+1.78%)
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today...

ARCT : 13.69 (+1.78%)
Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today...

ARCT : 13.69 (+1.78%)
Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis

Strategic manufacturing agreement includes Phase 3 clinical supply and commercial manufacturing rights

ARCT : 13.69 (+1.78%)
Arcturus Therapeutics Highlights mRNA Pipeline, CF Data and Vaccine Expansion at Jefferies

Arcturus Therapeutics (NASDAQ:ARCT) President and CEO Joseph Payne outlined the company’s messenger RNA programs, vaccine approvals and upcoming clinical milestones during a presentation at the Jefferies...

ARCT : 13.69 (+1.78%)
Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today...

ARCT : 13.69 (+1.78%)
Arcturus Therapeutics Q1 Earnings Call Highlights

Arcturus Therapeutics (NASDAQ:ARCT) executives highlighted progress in two rare-disease clinical programs and outlined a strengthened cash runway during the company’s first-quarter 2026 earnings call,...

ARCT : 13.69 (+1.78%)
Arcturus Therapeutics: Q1 Earnings Snapshot

Arcturus Therapeutics: Q1 Earnings Snapshot

ARCT : 13.69 (+1.78%)
Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress

Initiated enrollment (Q1 2026) earlier than expected for 12‑week cystic fibrosis (CF) open label Phase 2 study; lung function (ppFEV1 and LCI) is being monitored in Class I CF subjects ...

ARCT : 13.69 (+1.78%)

Business Summary

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system LUNAR(TM) and UNA Oligomer chemistry technologies. Arcturus Therapeutics Ltd, formerly known as...

See More

Key Turning Points

3rd Resistance Point 16.65
2nd Resistance Point 15.08
1st Resistance Point 14.26
Last Price 13.69
1st Support Level 11.87
2nd Support Level 10.30
3rd Support Level 9.48

See More

52-Week High 24.17
Fibonacci 61.8% 17.04
Fibonacci 50% 14.84
Last Price 13.69
Fibonacci 38.2% 12.63
52-Week Low 5.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.